Skip to content
  • People
  • Pipeline
  • Publications
  • News
Menu
  • People
  • Pipeline
  • Publications
  • News
  • People
  • Pipeline
  • Publications
  • News
  • Contact us
Menu
  • People
  • Pipeline
  • Publications
  • News
  • Contact us
Contact

Our CEO Jennifer Barnett will be speaking at the Neuroimmunology Drug Development Summit, taking place next week in Boston, MA

April 11, 2022

Our CEO Jennifer Barnett will be speaking at the Neuroimmunology Drug Development Summit, taking place next week in Boston, MA.

Don’t miss her in-person talk:
Using Digital Biomarkers to Apply a Stratified Approach to Neuroinflammation
When: April 19th, 9AM EST

Synopsis

  • Applying digital biomarkers, in combination with standard inflammatory markers, to aid identification of people at high risk for neuroinflammation
  • Using prophylactic small molecule approach for neuroinflammation to analyze neuroinflammatory outcomes in patients with post-operative cognitive decline in
  • Referencing the outcomes of the clinical trials conducted by Monument Tx to outline the above

Can’t attend the event but want to learn more our work applying digital biomarkers to aid identification of people at high risk for #neuroinflammation? Contact us directly: info@monumenttx.com

For further information, contact:

Jenny Barnett, CEO

E: jbarnett@monumenttx.com

Share on facebook
Share on twitter
Share on linkedin
PrevOlder
NewerNext

Contact Us

We believe that neuroscience will be in the next decade what oncology has been in the last decade.
Get in touch
MT LOGO WHITE PNG-01
info@monumenttx.com
© Copyright 2023  |  Privacy Policy & Terms of Use